Dupilumab-Associated Mycosis Fungoides with a CD8+ Immunophenotype

• Main Authors: Ariel Park (Author), Lulu Wong (Author), Annalise Lang (Author), Christina Kraus (Author), Nancy Anderson (Author), Ashley Elsensohn (Author)
• Format: Book
• Published: MDPI AG, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dupilumab is a humanized IgG4 monoclonal-antibody that is approved by the United States Food and Drug Administration (FDA) for the treatment of moderate-to-severe atopic dermatitis (AD) in patients aged 12 years and older. In recent years, several case studies have associated the unmasking or progre...